Teva Recalls Metoprolol Succinate 50 mg Due to Dissolution Failure
Teva Pharmaceuticals recalls specific lots of Metoprolol Succinate Extended-Release Tablets, 50 mg, due to failed dissolution specifications. Check your bottle's NDC and lot number.
Use caution until it’s fixed
Failed Dissolution Specifications
Contact the company
What happened, in plain English
Teva Pharmaceuticals USA, Inc. is recalling Metoprolol Succinate Extended-Release Tablets, 50 mg, because the medication may not dissolve properly in the body. This failure means patients might not receive the full dose needed to manage their condition effectively. The recall affects bottles containing 100 tablets and 1,000 tablets distributed nationwide. Read more at govinfonow.com/recall/31496-teva-recalls-metoprolol-succinate-50-mg-due-to-dissolution-failure.
Source Summary by GovInfoNow · govinfonow.com/recall/31496-teva-recalls-metoprolol-succinate-50-mg-due-to-dissolution-failure · Updated October 9, 2026 · FDA enforcement record: FDA #D-0355-2026
Cite this page
“Teva Recalls Metoprolol Succinate 50 mg Due to Dissolution Failure.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/31496-teva-recalls-metoprolol-succinate-50-mg-due-to-dissolution-failure. Based on FDA recall #D-0355-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0355-2026%22&limit=1).
Why it’s dangerous
The tablets failed dissolution specifications, meaning they may not break down and release the drug as intended in the digestive system. This can result in sub-therapeutic dosing, where the patient does not get enough medication to treat their heart or blood pressure condition effectively.
Who’s affected
Patients currently taking Metoprolol Succinate Extended-Release Tablets, 50 mg, prescribed by a doctor. Individuals who have purchased these specific bottles from pharmacies or healthcare providers across the United States are at risk of receiving ineffective medication.
How to tell if you have this one
Check your bottle for NDC 45963-676-11 (100 tablets) or NDC 45963-676-96 (1,000 tablets). Verify the lot number against the recall list: 0486G251, 0487G251, 0488G251, 0486G252, 0487G253, or 0488G252. All affected lots have an expiration date of 01/2027.
- Brand
Teva Pharmaceuticals- Category
Drug
All 4 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
Nationwide- NDC
45963-709-11, 45963-709-96, 45963-676-11, 45963-676-96, 45963-677-11, 45963-677-96, 45963-678-11
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0354-2026 | Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1,000 tablets bottles (NDC: 45963-709-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054; Lot#: a) 0715J251, Exp.: 12/2026; 0716J251, Exp.: 01/2027; 0717J251, Exp.: 01/2027; b) 0715J252, Exp.: 12/2026; 0716J252, Exp.: 01/2027, 0717J252, Exp.: 01/2027. | 18,780 bottles |
| D-0355-2026 | Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054; Lot#: a) 0486G251, 0487G251, 0488G251, Exp.: 01/2027; b) 0486G252, 0487G253, 0488G252, Exp.: 01/2027. | 67,043 bottles |
| D-0356-2026 | Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablets bottles (NDC: 45963-677-96), Teva Pharmaceuticals, Parsippany, NJ 07054.; Lot#: a) 0718J251, 0729J251, 0730J251, Exp.: 12/2026; b) 0718J252, 0729J252, 0730J252, Exp.: 12/2026. | 7,448 bottles |
| D-0357-2026 | Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11; Lot#: a) 0686H251, 0687H251, 10688H251, Exp.: 02/2027. . | 19,056 bottles |
What to do — step by step
Contact Your Pharmacist
Reach out to the pharmacy where you purchased the medication to confirm if your specific bottle is part of this recall.
Consult Your Doctor
Speak with your healthcare provider before stopping or changing your dosage to ensure your treatment plan remains safe and effective.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 41 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Teva Pharmaceuticals recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0355-2026 (January 29, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0355-2026 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.